This also opens the path toward the investigation of a possible relation of C4, activated via the classical or the lectin pathway, with platelet activation and/or endothelial dysfunction, irrespective of the extent of terminal pathway activation. The gene discussed is C4A; the disease is endothelial dysfunction.